CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 87 filers reported holding CARDIFF ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $419,000 | -59.1% | 168,902 | -0.9% | 0.01% | -54.5% |
| Q4 2021 | $1,024,000 | -12.6% | 170,447 | -3.1% | 0.02% | -15.4% |
| Q3 2021 | $1,171,000 | -33.6% | 175,827 | -33.7% | 0.03% | -31.6% |
| Q2 2021 | $1,763,000 | -29.1% | 265,128 | -1.2% | 0.04% | -24.0% |
| Q1 2021 | $2,485,000 | -12.3% | 268,373 | +70.4% | 0.05% | -21.9% |
| Q4 2020 | $2,834,000 | – | 157,535 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |